Dr Thomas Hanke
Head of Academic Partnerships at Evotec
Evotec is a drug discovery alliance and development partnership company. Since November 2016, Dr Hanke has been responsible for strategic academic partnerships at Evotec. He has also been Executive Vice President of Immunology and Inflammation since November 2013, heading a portfolio of drug discovery projects in the areas of inflammation and immuno-oncology. During this time, Dr Hanke’s focus has been on building high-value, performance based drug discovery alliances with academia and pharma.
Dr. Hanke is in Oxford as LAB282's expert in residence and is working closely with academics and Oxford University Innovation to source and manage funded projects. Read more about LAB282 and Dr Hanke's involvement.
If you would like to discuss projects please contact Richard Reschen (email@example.com).